5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.91▲ | 3.90▲ | 3.88▲ | 3.85▲ | 3.82▲ |
MA10 | 3.91▲ | 3.88▲ | 3.87▲ | 3.75▲ | 4.06▼ |
MA20 | 3.89▲ | 3.86▲ | 3.84▲ | 3.80▲ | 4.21▼ |
MA50 | 3.85▲ | 3.81▲ | 3.75▲ | 4.25▼ | 4.24▼ |
MA100 | 3.82▲ | 3.76▲ | 3.80▲ | 4.24▼ | 13.06▼ |
MA200 | 3.77▲ | 3.80▲ | 3.88▲ | 4.27▼ | 156.81▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.003▲ | 0.005▲ | 0.042▲ | 0.002▲ |
RSI | 59.011▲ | 59.752▲ | 60.872▲ | 50.386▲ | 44.575▼ |
STOCH | 90.000▲ | 84.091▲ | 68.398 | 66.712 | 15.342▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -23.841▲ | -81.961▼ |
CCI | 82.099 | 98.114 | 120.850▲ | 55.679 | -57.529 |
Friday, September 19, 2025 08:17 AM
In a Sept. 18 report, Roth Capital Markets analyst Boobalan Pachaiyappan reiterated a “Buy” rating and US$10.00 target on Cingulate ...
|
Wednesday, September 17, 2025 05:57 AM
Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA ApprovalKANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a ...
|
Thursday, August 21, 2025 02:36 PM
Dallas, Texas--(Newsfile Corp. - August 21, 2025) - Cingulate Inc. (CING) (NASDAQ: CING): Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate reported 2Q25 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 3.88 | 3.934 | 3.80 | 3.92 | 90,114 |
29/09/25 | 3.88 | 3.95 | 3.82 | 3.89 | 101,900 |
26/09/25 | 3.73 | 3.8558 | 3.70 | 3.81 | 90,613 |
25/09/25 | 3.75 | 3.85 | 3.70 | 3.79 | 60,136 |
24/09/25 | 3.73 | 3.87 | 3.68 | 3.83 | 227,300 |
23/09/25 | 3.80 | 3.89 | 3.65 | 3.65 | 121,149 |
22/09/25 | 3.58 | 3.84 | 3.47 | 3.82 | 231,378 |
19/09/25 | 3.53 | 3.635 | 3.46 | 3.54 | 244,006 |
18/09/25 | 3.73 | 3.82 | 3.515 | 3.52 | 295,500 |
17/09/25 | 3.83 | 3.93 | 3.62 | 3.70 | 483,707 |
|
|
||||
|
|
||||
|
|